These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 27890424)

  • 21. Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling.
    Kristensen H; Thomsen AR; Haldrup C; Dyrskjøt L; Høyer S; Borre M; Mouritzen P; Ørntoft TF; Sørensen KD
    Oncotarget; 2016 May; 7(21):30760-71. PubMed ID: 27120795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of microRNA signature and potential pathway targets in prostate cancer.
    Moustafa AA; Ziada M; Elshaikh A; Datta A; Kim H; Moroz K; Srivastav S; Thomas R; Silberstein JL; Moparty K; Salem FE; El-Habit OH; Abdel-Mageed AB
    Exp Biol Med (Maywood); 2017 Mar; 242(5):536-546. PubMed ID: 27903835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs in prostate cancer: From function to biomarker discovery.
    Moustafa AA; Kim H; Albeltagy RS; El-Habit OH; Abdel-Mageed AB
    Exp Biol Med (Maywood); 2018 Jun; 243(10):817-825. PubMed ID: 29932371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?
    Schubert M; Junker K; Heinzelmann J
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1673-95. PubMed ID: 26660324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary biomarkers in prostate cancer detection and monitoring progression.
    Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
    Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer.
    Coradduzza D; Cruciani S; Arru C; Garroni G; Pashchenko A; Jedea M; Zappavigna S; Caraglia M; Amler E; Carru C; Maioli M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Serum microRNA Biomarkers to Predict Reclassification of Prostate Cancer in Patients on Active Surveillance.
    Liu RSC; Olkhov-Mitsel E; Jeyapala R; Zhao F; Commisso K; Klotz L; Loblaw A; Liu SK; Vesprini D; Fleshner NE; Bapat B
    J Urol; 2018 Jun; 199(6):1475-1481. PubMed ID: 29246734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA in prostate cancer.
    Khanmi K; Ignacimuthu S; Paulraj MG
    Clin Chim Acta; 2015 Dec; 451(Pt B):154-60. PubMed ID: 26415820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer.
    Gonzales JC; Fink LM; Goodman OB; Symanowski JT; Vogelzang NJ; Ward DC
    Clin Genitourin Cancer; 2011 Sep; 9(1):39-45. PubMed ID: 21723797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
    Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
    Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA in prostate cancer: Practical aspects.
    Patil PA; Magi-Galluzzi C
    Histol Histopathol; 2015 Dec; 30(12):1379-96. PubMed ID: 26186079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
    Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K
    Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep sequencing of small RNA libraries from human prostate epithelial and stromal cells reveal distinct pattern of microRNAs primarily predicted to target growth factors.
    Singh S; Zheng Y; Jagadeeswaran G; Ebron JS; Sikand K; Gupta S; Sunker R; Shukla GC
    Cancer Lett; 2016 Feb; 371(2):262-73. PubMed ID: 26655274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-301a expression: Diagnostic and prognostic marker for prostate cancer.
    Kolluru V; Chandrasekaran B; Tyagi A; Dervishi A; Ankem M; Yan X; Maiying K; Alatassi H; Shaheen SP; C Messer J; Edwards A; Haddad A; Damodaran C
    Urol Oncol; 2018 Nov; 36(11):503.e9-503.e15. PubMed ID: 30195463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating miRNAs are correlated with tumor progression in prostate cancer.
    Brase JC; Johannes M; Schlomm T; Fälth M; Haese A; Steuber T; Beissbarth T; Kuner R; Sültmann H
    Int J Cancer; 2011 Feb; 128(3):608-16. PubMed ID: 20473869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coordinate microRNA-mediated regulation of protein complexes in prostate cancer.
    Alshalalfa M; Bader GD; Bismar TA; Alhajj R
    PLoS One; 2013; 8(12):e84261. PubMed ID: 24391925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification of prostate cancer 2016.
    Reiter RE
    Scand J Clin Lab Invest Suppl; 2016; 245():S54-9. PubMed ID: 27533326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome.
    Jeon J; Olkhov-Mitsel E; Xie H; Yao CQ; Zhao F; Jahangiri S; Cuizon C; Scarcello S; Jeyapala R; Watson JD; Fraser M; Ray J; Commisso K; Loblaw A; Fleshner NE; Bristow RG; Downes M; Vesprini D; Liu S; Bapat B; Boutros PC
    J Natl Cancer Inst; 2020 Mar; 112(3):247-255. PubMed ID: 31161221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.